ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX
GlobeNewswire·2025-01-16 01:45
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the “Class Period”). A lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 14, 2025. SO WHAT: If you purchased Pacira securities during the Class Period, ...